Search research articles
Contact Us
Filters
Showing results (331-340 of 713) with videos related to
Page
of 72
Sort By:
Seminars in Oncology
|
May 3, 2008
Optimizing outcomes for patients with advanced disease in chronic myelogenous leukemia
Francis J Giles, Daniel J DeAngelo, Michele Baccarani, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE
|
December 29, 2023
Antifungal stewardship: the Latin American experience
Fernando Riera, Jorge Cortes Luna, Ricardo Rabagliatti, et al.
Cancer
|
July 29, 2010
Current patient management of chronic myeloid leukemia in Latin America: a study by the Latin American Leukemia Net (LALNET)
Jorge Cortes, Carmino De Souza, Manuel Ayala-Sanchez, et al.
Cancer
|
June 19, 2009
Dasatinib or high-dose imatinib for chronic-phase chronic myeloid leukemia resistant to imatinib at a dose of 400 to 600 milligrams daily: two-year follow-up of a randomized phase 2 study (START-R)
Hagop Kantarjian, Ricardo Pasquini, Vincent Lévy, et al.
Leukemia & Lymphoma
|
May 25, 2019
Outcomes of patients with chronic phase chronic myeloid leukemia (CML-CP) after discontinuation of frontline ponatinib therapy
Prajwal Boddu, Preetesh Jain, Gautam Borthakur, et al.
Cancer
|
December 18, 2008
Therapy-related acute myelogenous leukemia and myelodysplastic syndrome in patients with acute lymphoblastic leukemia treated with the hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone regimens
Dushyant Verma, Susan O'Brien, Deborah Thomas, et al.
Leukemia Research
|
August 22, 2008
Circulating heat shock protein 70 and progression in patients with chronic myeloid leukemia
Chen-Hsiung Yeh, Richard Tseng, Zhong Zhang, et al.
Leukemia & Lymphoma
|
August 15, 2014
Incidence of secondary neoplasms in patients with acute promyelocytic leukemia treated with all-trans retinoic acid plus chemotherapy or with all-trans retinoic acid plus arsenic trioxide
Alireza Eghtedar, Ildefonso Rodriguez, Hagop Kantarjian, et al.
Journal of Health Care for the Poor and Underserved
|
August 18, 2025
A Report on Georgia Cancer Disparities and an Economic Evaluation of a Statewide Cancer Clinicians and Scholars' Program
Jon A Hoin, Kylie Brown, Joseph Lipscomb, et al.
British Journal of Haematology
|
June 18, 2010
Clinical impact of dose reductions and interruptions of second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukaemia
Fabio P S Santos, Hagop Kantarjian, Carmen Fava, et al.
Page
of 72
Search research articles
Search
Showing results (331-340 of 713) with videos related to
Sort By:
Page
of 72
Seminars in Oncology
|
May 3, 2008
Optimizing outcomes for patients with advanced disease in chronic myelogenous leukemia
Francis J Giles, Daniel J DeAngelo, Michele Baccarani, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE
|
December 29, 2023
Antifungal stewardship: the Latin American experience
Fernando Riera, Jorge Cortes Luna, Ricardo Rabagliatti, et al.
Cancer
|
July 29, 2010
Current patient management of chronic myeloid leukemia in Latin America: a study by the Latin American Leukemia Net (LALNET)
Jorge Cortes, Carmino De Souza, Manuel Ayala-Sanchez, et al.
Cancer
|
June 19, 2009
Dasatinib or high-dose imatinib for chronic-phase chronic myeloid leukemia resistant to imatinib at a dose of 400 to 600 milligrams daily: two-year follow-up of a randomized phase 2 study (START-R)
Hagop Kantarjian, Ricardo Pasquini, Vincent Lévy, et al.
Leukemia & Lymphoma
|
May 25, 2019
Outcomes of patients with chronic phase chronic myeloid leukemia (CML-CP) after discontinuation of frontline ponatinib therapy
Prajwal Boddu, Preetesh Jain, Gautam Borthakur, et al.
Cancer
|
December 18, 2008
Therapy-related acute myelogenous leukemia and myelodysplastic syndrome in patients with acute lymphoblastic leukemia treated with the hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone regimens
Dushyant Verma, Susan O'Brien, Deborah Thomas, et al.
Leukemia Research
|
August 22, 2008
Circulating heat shock protein 70 and progression in patients with chronic myeloid leukemia
Chen-Hsiung Yeh, Richard Tseng, Zhong Zhang, et al.
Leukemia & Lymphoma
|
August 15, 2014
Incidence of secondary neoplasms in patients with acute promyelocytic leukemia treated with all-trans retinoic acid plus chemotherapy or with all-trans retinoic acid plus arsenic trioxide
Alireza Eghtedar, Ildefonso Rodriguez, Hagop Kantarjian, et al.
Journal of Health Care for the Poor and Underserved
|
August 18, 2025
A Report on Georgia Cancer Disparities and an Economic Evaluation of a Statewide Cancer Clinicians and Scholars' Program
Jon A Hoin, Kylie Brown, Joseph Lipscomb, et al.
British Journal of Haematology
|
June 18, 2010
Clinical impact of dose reductions and interruptions of second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukaemia
Fabio P S Santos, Hagop Kantarjian, Carmen Fava, et al.
Page
of 72